TOKYO (Reuters) – AstraZeneca said on Friday it had applied for approval in Japan for its COVID-19 vaccine, making it the second drug maker to do so after Pfizer Inc.
The Japanese government in December signed a contract to procure 120 million doses of AstraZeneca vaccine, enough for 60 million people.
(Reporting by Kiyoshi Takenaka; Editing by Tom Hogue)
